Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST
Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to investigate the tolerability of enecadin in patients
with acute ischemic stroke. Furthermore, the pharmacokinetics of enecadin in both male and
female patients with acute ischemic stroke will be assessed. Efficacy trends will be
evaluated up to day 30 post stroke.